Estimated value of productivity lost due to childhood chickenpox in the United Kingdom: a survey of parents

Wittenberg, Raphael ORCID: 0000-0003-3096-2721, Damant, Jacqueline ORCID: 0000-0003-1425-272X, Rehill, Amritpal ORCID: 0000-0003-3826-2711, Knapp, Martin ORCID: 0000-0003-1427-0215, Adeyemi, Tobi and Matthews, Ian (2024) Estimated value of productivity lost due to childhood chickenpox in the United Kingdom: a survey of parents. Expert Review of Pharmacoeconomics and Outcomes Research. ISSN 1473-7167

Text (spsr-article-p322_5 (1)) - Published Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (548kB)

• Author
• Author
• Author
• Author
• Scopus publication

Abstract

Background: While medical costs of chickenpox have been researched, little is known about indirect costs. Understanding total costs is important for decisions about vaccination. This study estimated the value of lost productivity of adults missing work to care for children with chickenpox. Research design and methods: It comprised an international literature review, an online survey of 1,526 parents of children aged 1–11 years, and computation of indirect costs of chickenpox in the UK. The survey covered chickenpox episodes amongst respondents’ children, time children took off school/nursery, and work absenteeism by parents/caregivers caring for them. Results: Respondents reported on 2,283 children, of whom 52% (1185/2283) experienced chickenpox. Almost half (591/1185) missed days of school/nursery, averaging 5.6 days missed. In 260 cases of 542 adults providing data with such a child, an adult missed work to care for the child. The daily value of this lost productivity was £170. There were approximately 200,000 GP consultations for chickenpox and 625,000 births annually, suggesting the annual chickenpox incidence lies between these figures. The estimated annual UK productivity loss due to chickenpox is £20–£70 million ($25–$90 million). Conclusions: Annual value of lost productivity due to chickenpox is in range £20 to £70 million.

Item Type:	Article
Additional Information:	© 2024 The Author(s)
Divisions:	Care Policy and Evaluation Centre Health Policy
Subjects:	R Medicine > RJ Pediatrics > RJ101 Child Health. Child health services
Date Deposited:	16 Aug 2024 10:52
Last Modified:	12 Dec 2024 04:25
URI:	http://eprints.lse.ac.uk/id/eprint/124581

Actions (login required)

View Item